Search clinical trials for: tivozanib hydrochloride
Total 7350 results
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer Network; AVEO Pharmaceuticals, Inc.TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedHepatic ImpairmentUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer Network; AVEO...CompletedAdvanced Adult Hepatocellular Carcinoma | Non-Resectable Hepatocellular CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedCarcinoma, Renal CellUnited States, Hungary, Spain, United Kingdom, Italy, Germany, France, Belgium, Czechia, Canada, Denmark, Poland
-
AVEO Pharmaceuticals, Inc.Completed
-
AVEO Pharmaceuticals, Inc.Astellas Pharma IncTerminatedTriple Negative Breast CancerGermany, Taiwan, Spain, Ukraine, Australia, Korea, Republic of, Canada, United States, Italy, Bahamas
-
AVEO Pharmaceuticals, Inc.CompletedRenal Cell CarcinomaUnited States, Canada
-
AVEO Pharmaceuticals, Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompleted
-
Emory UniversityAVEO Pharmaceuticals, Inc.Terminated
-
AVEO Pharmaceuticals, Inc.CompletedFood Effect of Tivozanib in Health SubjectsUnited States
-
AVEO Pharmaceuticals, Inc.Astellas Pharma IncTerminatedMetastatic Renal Cell CarcinomaFrance, United Kingdom, Germany, Spain, Belgium, United States, Italy
-
AVEO Pharmaceuticals, Inc.CompletedColorectal Cancer | Gastrointestinal CancerNetherlands
-
AVEO Pharmaceuticals, Inc.TerminatedSolid TumorsUnited States, Canada, Netherlands, India, Russian Federation, Ukraine
-
AVEO Pharmaceuticals, Inc.Completed
-
AVEO Pharmaceuticals, Inc.Completed
-
AVEO Pharmaceuticals, Inc.CompletedCarcinoma, Renal CellUkraine, India, Russian Federation
-
University of UtahWithdrawnNon-small Cell Lung Cancer | Stage IV Disease | EGFR Unknown or Wild-type
-
National Cancer Institute (NCI)RecruitingCholangiocarcinoma | Bile Duct Neoplasm | Biliary Tract MalignancyUnited States
-
Bristol-Myers SquibbActive, not recruitingPsoriasisChina, Taiwan, Spain, United States, Hungary, Canada, Germany, Japan, Australia, Poland, Czechia, United Kingdom, Korea, Republic of, Israel, New Zealand, Sweden, France, Finland, Russian Federation, Puerto Rico
-
Northwestern UniversityNational Comprehensive Cancer NetworkCompletedRecurrent Fallopian Tube Cancer | Recurrent Epithelial Ovarian Cancer | Recurrent Primary Peritoneal CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
Northwestern UniversityAVEO Pharmaceuticals, Inc.CompletedRecurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue SarcomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedGastrointestinal CancerUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkActive, not recruiting
-
Roswell Park Cancer InstituteAVEO Pharmaceuticals, Inc.WithdrawnStage III Renal Cell Cancer | Stage II Renal Cell Cancer
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Locally Advanced or Metastatic Breast or Colorectal CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
AVEO Pharmaceuticals, Inc.AstraZenecaTerminatedHepatocellular CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.Bristol-Myers Squibb; ParexelActive, not recruitingRenal Cell CarcinomaCanada, Italy, Spain, United States, United Kingdom, Australia, Germany, Poland, Belgium, Portugal, Czechia, Brazil, France, Argentina, Chile, Mexico
-
AVEO Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedCarcinoma, Renal CellFrance
-
University of FloridaGenentech, Inc.; Aveo Oncology PharmaceuticalsRecruitingSoft Tissue Sarcoma | Breast Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Prostate Cancer | Neuroendocrine Tumors | Vulvar Cancer | Bile Duct Cancer | Gall Bladder CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
AVEO Pharmaceuticals, Inc.Completed
-
Neelesh Sharma MD PhDCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteWithdrawn
-
Xijing Hospital of Digestive DiseasesCompleted
-
Xijing Hospital of Digestive DiseasesCompletedColorectal AdenomasChina
-
Shenyang Sunshine Pharmaceutical Co., LTD.UnknownUremic PruritusChina
-
Galderma R&DCompleted
-
AVEO Pharmaceuticals, Inc.CompletedColorectal CancerUnited States, Hungary, United Kingdom, Australia, Spain, Netherlands, Italy, Czech Republic, Canada, Austria, Belgium, Finland
-
M.D. Anderson Cancer CenterWithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdCompleted
-
EpygenixCompletedDravet SyndromeUnited States
-
Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological | EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria
-
Advanz PharmaCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Peking University Third HospitalNot yet recruitingNon-Small Cell Lung Cancer
-
M.D. Anderson Cancer CenterAVEO Pharmaceuticals, Inc.RecruitingPhase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaUnited States